Global Biotech Contract for ISS

ISS has won a five-year contract with a phased-in commencement from 1 June 2017 which builds on its existing customer relationship with global biotechnology company, Shire.

ISS, a global leading facility services provider, has won a five-year contract with a phased-in commencement from 1 June 2017, which builds on an existing customer relationship with Shire, a global biotechnology company. The contract's scope and geographical footprint are now expanded to include more than 40 countries.

The integrated solution will allow Shire to focus on their core business while ISS focuses on optimising and standardising select non-core processes within integrated facilities management, maintenance, and engineering. The goal is to drive consistency, better performance, improved service levels, and enhanced management of expenses.

Andrew Price, ISS Group Chief Commercial Officer, said:
"We are very proud that we are entrusted with this global Integrated Facility Service contract. It shows the level of trust and partnership we have built to date and we remain committed to providing high-quality and reliable services to help reduce complexity and mitigate risk."
The services cover catering, janitorial, building maintenance, waste management, pest control, landscaping, cleaning, uniforms & gowning, security, and other facility services.
ISS' Integrated Facility Services offering provides the customer with all the services they need at a uniform quality level across the board, delivered by a single provider.
ISS has a large customer portfolio within pharma and biotech companies and has a strong understanding of the complexity and the level of compliance and quality needed to service the industry.